|
US4713249A
(en)
|
1981-11-12 |
1987-12-15 |
Schroeder Ulf |
Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
|
|
EP0116208B1
(en)
|
1982-12-07 |
1988-03-30 |
Kyowa Hakko Kogyo Co., Ltd. |
Mitomycin analogues
|
|
JPS60255789A
(ja)
|
1984-06-01 |
1985-12-17 |
Kyowa Hakko Kogyo Co Ltd |
マイトマイシン誘導体，その製造法および抗腫瘍剤
|
|
US5266333A
(en)
|
1985-03-06 |
1993-11-30 |
American Cyanamid Company |
Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
|
|
US5103018A
(en)
*
|
1986-08-26 |
1992-04-07 |
Kyowa Hakko Kogyo Kabushiki Kaisha |
Mitomycin derivatives
|
|
CA2044590A1
(en)
|
1989-11-13 |
1991-05-14 |
Marc D. Better |
Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
|
|
US5627165A
(en)
*
|
1990-06-13 |
1997-05-06 |
Drug Innovation & Design, Inc. |
Phosphorous prodrugs and therapeutic delivery systems using same
|
|
AU653565B2
(en)
*
|
1990-12-21 |
1994-10-06 |
Nikken Corporation |
Raw sewage disposal apparatus and prefab for accomodating the same
|
|
US6291196B1
(en)
|
1992-01-31 |
2001-09-18 |
Research Corporation Technologies, Inc. |
Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
|
|
US7070782B1
(en)
*
|
1992-11-05 |
2006-07-04 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US6569432B1
(en)
*
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
JP3538221B2
(ja)
|
1993-11-19 |
2004-06-14 |
富士写真フイルム株式会社 |
定着濃厚液およびそれを用いたハロゲン化銀写真感光材料の処理方法
|
|
US5417982A
(en)
|
1994-02-17 |
1995-05-23 |
Modi; Pankaj |
Controlled release of drugs or hormones in biodegradable polymer microspheres
|
|
US5866679A
(en)
|
1994-06-28 |
1999-02-02 |
Merck & Co., Inc. |
Peptides
|
|
US6946133B1
(en)
|
1996-03-20 |
2005-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Prostate specific antigen oligo-epitope peptide
|
|
AU726914B2
(en)
|
1996-04-01 |
2000-11-23 |
Epix Pharmaceuticals, Inc. |
Bioactivated diagnostic imaging contrast agents
|
|
CA2251186A1
(en)
|
1996-04-05 |
1997-10-16 |
The Johns Hopkins University |
A method of enriching rare cells
|
|
US5795877A
(en)
|
1996-12-31 |
1998-08-18 |
Guilford Pharmaceuticals Inc. |
Inhibitors of NAALADase enzyme activity
|
|
US5902817A
(en)
|
1997-04-09 |
1999-05-11 |
Guilford Pharmaceuticals Inc. |
Certain sulfoxide and sulfone derivatives
|
|
US6054444A
(en)
*
|
1997-04-24 |
2000-04-25 |
Guilford Pharmaceuticals Inc. |
Phosphonic acid derivatives
|
|
US5672592A
(en)
|
1996-06-17 |
1997-09-30 |
Guilford Pharmaceuticals Inc. |
Certain phosphonomethyl-pentanedioic acid derivatives thereof
|
|
US5863536A
(en)
|
1996-12-31 |
1999-01-26 |
Guilford Pharmaceuticals Inc. |
Phosphoramidate derivatives
|
|
US5998362A
(en)
|
1996-09-12 |
1999-12-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US6368598B1
(en)
|
1996-09-16 |
2002-04-09 |
Jcrt Radiation Oncology Support Services, Inc. |
Drug complex for treatment of metastatic prostate cancer
|
|
US5962521A
(en)
|
1997-04-04 |
1999-10-05 |
Guilford Pharmaceuticals Inc. |
Hydroxamic acid derivatives
|
|
US6177404B1
(en)
|
1996-10-15 |
2001-01-23 |
Merck & Co., Inc. |
Conjugates useful in the treatment of benign prostatic hyperplasia
|
|
US5948750A
(en)
|
1996-10-30 |
1999-09-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
JP3981416B2
(ja)
|
1997-04-10 |
2007-09-26 |
ユニバーシティ メディカル センター ナイメーヘン |
Ｐｃａ３タンパク質、ｐｃａ３遺伝子、及びこれらの用途
|
|
US6127333A
(en)
|
1997-07-10 |
2000-10-03 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US6391305B1
(en)
|
1997-09-10 |
2002-05-21 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US20020115596A1
(en)
|
1997-10-27 |
2002-08-22 |
Merk & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
ZA9810974B
(en)
*
|
1997-12-02 |
1999-06-03 |
Merck & Co Inc |
Conjugates useful in the treatment of prostate cancer
|
|
HRP20000367A2
(en)
|
1997-12-02 |
2000-12-31 |
Merck & Co Inc |
Conjugates useful in the treatment of prostate cancer
|
|
US20040081659A1
(en)
|
1997-12-02 |
2004-04-29 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
AU2896399A
(en)
*
|
1998-03-03 |
1999-09-20 |
Exact Sciences Corporation |
Purification and detection processes using reversible affinity electrophoresis
|
|
US20020103136A1
(en)
|
1998-03-05 |
2002-08-01 |
Dong-Mei Feng |
Conjugates useful in the treatment of prostate cancer
|
|
US6232287B1
(en)
|
1998-03-13 |
2001-05-15 |
The Burnham Institute |
Molecules that home to various selected organs or tissues
|
|
US6093382A
(en)
|
1998-05-16 |
2000-07-25 |
Bracco Research Usa Inc. |
Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
|
|
AU757698C
(en)
|
1998-06-01 |
2004-04-08 |
Agensys, Inc. |
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US20070020327A1
(en)
|
1998-11-10 |
2007-01-25 |
John Fikes |
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
|
|
US6174858B1
(en)
|
1998-11-17 |
2001-01-16 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US20030207808A1
(en)
|
1999-02-18 |
2003-11-06 |
Kinneret Savitzky |
Novel nucleic acid and amino acid sequences
|
|
WO2000059930A1
(en)
|
1999-04-05 |
2000-10-12 |
Merck & Co., Inc. |
A method of treating cancer
|
|
US6528499B1
(en)
*
|
2000-04-27 |
2003-03-04 |
Georgetown University |
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
|
|
CA2367787C
(en)
|
1999-04-28 |
2011-07-26 |
Alan P. Kozikowski |
Ligands for metabotropic glutamate receptors
|
|
AUPQ014799A0
(en)
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using polymers
|
|
US7166573B1
(en)
|
1999-05-28 |
2007-01-23 |
Ludwig Institute For Cancer Research |
Breast, gastric and prostate cancer associated antigens and uses therefor
|
|
US20040146516A1
(en)
*
|
1999-06-17 |
2004-07-29 |
Utah Ventures Ii L.P. |
Lumen-exposed molecules and methods for targeted delivery
|
|
US7361338B2
(en)
|
1999-10-05 |
2008-04-22 |
Agensys, Inc. |
Methods to inhibit growth of prostate cancer cells
|
|
US6692724B1
(en)
|
1999-10-25 |
2004-02-17 |
Board Of Regents, The University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
|
US6428785B1
(en)
|
1999-10-28 |
2002-08-06 |
Immunolytics Inc. |
Method and composition for treating prostate cancer
|
|
CA2391534A1
(en)
*
|
1999-11-15 |
2001-05-25 |
Drug Innovation & Design, Inc. |
Selective cellular targeting: multifunctional delivery vehicles
|
|
PL211872B1
(pl)
|
2000-03-31 |
2012-07-31 |
Purdue Research Foundation |
Kompozycja farmaceutyczna
|
|
US20030072794A1
(en)
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
|
AU2002224401B2
(en)
*
|
2000-10-16 |
2007-12-06 |
Gilead Sciences, Inc. |
Nucleic acid ligands to the prostate specific membrane antigen
|
|
US20020132983A1
(en)
|
2000-11-30 |
2002-09-19 |
Junghans Richard P. |
Antibodies as chimeric effector cell receptors against tumor antigens
|
|
AU2002239403A1
(en)
|
2000-12-01 |
2002-06-11 |
The Johns Hopkins University |
Tissue specific prodrugs
|
|
EP1390081A2
(en)
*
|
2001-01-08 |
2004-02-25 |
Neorx Corporation |
Therapeutic and diagnostic compounds, compositions, and methods
|
|
WO2002098885A1
(en)
|
2001-02-07 |
2002-12-12 |
Beth Israel Deaconess Medical Center |
Modified psma ligands and uses related thereto
|
|
WO2002074345A2
(en)
|
2001-03-16 |
2002-09-26 |
Johns Hopkins University School Of Medicine |
Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules
|
|
EP1389209B1
(en)
*
|
2001-04-24 |
2009-04-08 |
Purdue Research Foundation |
Folate mimetics and folate-receptor binding conjugates thereof
|
|
CA2445826C
(en)
|
2001-05-02 |
2014-03-25 |
Purdue Research Foundation |
Treatment and diagnosis of macrophage mediated disease
|
|
US7109165B2
(en)
*
|
2001-05-18 |
2006-09-19 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
|
US7514078B2
(en)
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
|
EP2277542B1
(en)
|
2001-06-01 |
2014-04-16 |
Cornell Research Foundation Inc. |
Modified antibodies to prostrate-specific membrane antigen and uses thereof
|
|
US20040018203A1
(en)
*
|
2001-06-08 |
2004-01-29 |
Ira Pastan |
Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates
|
|
DE60232244D1
(de)
|
2001-06-21 |
2009-06-18 |
Glycomimetics Inc |
Nachweis und behandlung von prostatakrebs
|
|
US20030031677A1
(en)
*
|
2001-06-25 |
2003-02-13 |
Drug Innovation & Design, Incorporated |
Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications
|
|
US7893223B2
(en)
|
2001-07-17 |
2011-02-22 |
Bracco Imaging S.P.A. |
Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
|
|
PT1567641E
(pt)
|
2001-08-24 |
2012-08-21 |
Uvic Industry Partnerships Inc |
Proaerolisina contendo sequência de activação de proteases e métodos de uso para o tratamento do cancro da próstata
|
|
IL159422A0
(en)
|
2001-09-20 |
2004-06-01 |
Cornell Res Foundation Inc |
Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate-specific membrane antigen
|
|
US20030232760A1
(en)
|
2001-09-21 |
2003-12-18 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
KR20040053136A
(ko)
|
2001-09-28 |
2004-06-23 |
펄듀 리서치 파운데이션 |
리간드-면역원 공액체를 이용한 치료 방법
|
|
US20030215456A1
(en)
|
2001-10-02 |
2003-11-20 |
Sui-Long Yao |
Method of treating cancer
|
|
US20030133927A1
(en)
|
2001-10-10 |
2003-07-17 |
Defeo-Jones Deborah |
Conjugates useful in the treatment of prostate cancer
|
|
US20040058857A1
(en)
|
2001-11-29 |
2004-03-25 |
Siu-Long Yao |
Method of treating cancer
|
|
US20070031438A1
(en)
|
2001-12-10 |
2007-02-08 |
Junghans Richard P |
Antibodies as chimeric effector cell receptors against tumor antigens
|
|
AU2003205077A1
(en)
|
2002-01-10 |
2003-07-30 |
Johns Hopkins University |
Imaging agents and methods of imaging naaladase of psma
|
|
US7344700B2
(en)
*
|
2002-02-28 |
2008-03-18 |
University Of Tennessee Research Corporation |
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
|
EP1497462A4
(en)
|
2002-03-07 |
2007-11-07 |
Univ Johns Hopkins Med |
GENOMIC SCREEN ON EPIGENETIC MUTED CANCER ASSOCIATED GENES
|
|
US7534580B2
(en)
|
2002-05-01 |
2009-05-19 |
Ambrilia Biopharma Inc. |
PSP94 diagnostic reagents and assays
|
|
DK2260875T3
(da)
|
2002-05-06 |
2014-06-30 |
Endocyte Inc |
Folatreceptor-targetede billeddannelsesmidler
|
|
WO2003097647A1
(en)
|
2002-05-15 |
2003-11-27 |
Endocyte, Inc. |
Vitamin-mitomycin conjugates
|
|
US7767803B2
(en)
*
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
|
JP2004064945A
(ja)
|
2002-07-31 |
2004-02-26 |
Hitachi Koki Co Ltd |
回転体駆動装置
|
|
AR040956A1
(es)
*
|
2002-07-31 |
2005-04-27 |
Schering Ag |
Nuevos conjugados de efectores, procedimientos para su preparacion y su uso farmaceutico
|
|
SI1545613T1
(sl)
|
2002-07-31 |
2011-11-30 |
Seattle Genetics Inc |
Avristatinski konjugati in njihova uporaba za zdravljenje raka avtoimunske bolezni ali infekcijskebolezni
|
|
WO2006028429A2
(en)
*
|
2002-08-05 |
2006-03-16 |
The Johns Hopkins University |
Peptides for targeting the prostate specific membrane antigen
|
|
AU2003259761A1
(en)
|
2002-08-08 |
2004-02-25 |
Johns Hopkins University |
Enhancement of adenoviral oncolytic activity in prostate cells by modification of the e1a gene product
|
|
US8487128B2
(en)
|
2002-11-26 |
2013-07-16 |
Chs Pharma, Inc. |
Protection of normal cells
|
|
US7875586B2
(en)
|
2002-12-20 |
2011-01-25 |
The Johns Hopkins University |
Treatment of metastatic colon cancer with b-subunit of shiga toxin
|
|
US20080008649A1
(en)
|
2003-01-13 |
2008-01-10 |
Bracco Imaging S.P.A. |
Gastrin Releasing Peptide Compounds
|
|
US7226577B2
(en)
|
2003-01-13 |
2007-06-05 |
Bracco Imaging, S. P. A. |
Gastrin releasing peptide compounds
|
|
DK1592457T3
(da)
|
2003-01-27 |
2012-10-22 |
Endocyte Inc |
Folat-vinblastin-konjugat som lægemiddel
|
|
EP1587837B1
(en)
|
2003-01-28 |
2012-06-13 |
Proscan RX Pharma Inc. |
Epitope sequences for prostate cancer diagnosis and treatment
|
|
US7638122B2
(en)
|
2003-03-07 |
2009-12-29 |
University Of South Florida |
Stat3 antagonists and their use as vaccines against cancer
|
|
WO2004080412A2
(en)
*
|
2003-03-07 |
2004-09-23 |
The University Of Toledo |
Paclitaxel hybrid derivatives
|
|
US20070179100A1
(en)
|
2003-04-09 |
2007-08-02 |
Muthiah Manoharan |
Protected monomers
|
|
DK1620544T3
(en)
*
|
2003-04-17 |
2019-01-14 |
Alnylam Pharmaceuticals Inc |
MODIFIED iRNA AGENTS
|
|
EP1641742A4
(en)
|
2003-05-01 |
2006-11-29 |
Nst Neurosurvival Technologies |
COMPOUNDS BINDING SELECTIVELY TO MEMBRANES OF APOPTOTIC CELLS
|
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
|
CA2529027C
(en)
*
|
2003-06-13 |
2013-09-10 |
Immunomedics, Inc. |
D-amino acid peptides
|
|
US7232805B2
(en)
*
|
2003-09-10 |
2007-06-19 |
Inflabloc Pharmaceuticals, Inc. |
Cobalamin conjugates for anti-tumor therapy
|
|
US20050255042A1
(en)
|
2003-11-24 |
2005-11-17 |
The Regents Of The University Of California Office Of Technology Transfer, University Of California |
On-demand cleavable linkers for radioconjugates for cancer imaging and therapy
|
|
FR2864546A1
(fr)
*
|
2003-12-24 |
2005-07-01 |
Assist Publ Hopitaux De Paris |
Methode d'identification et de preparation de lymphocytes t regulateurs/suppresseurs, compositions et utilisations
|
|
US8586932B2
(en)
|
2004-11-09 |
2013-11-19 |
Spectrum Dynamics Llc |
System and method for radioactive emission measurement
|
|
DE102004004787A1
(de)
*
|
2004-01-30 |
2005-08-18 |
Schering Ag |
Neue Effektor-Konjugate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
|
EP1718667B1
(en)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
EP1723430A2
(fr)
|
2004-03-03 |
2006-11-22 |
Biomerieux |
Procede de detection de la forme libre activable du psa et son utilisation pour le diagnostic des pathologies benignes de la prostate et de l adenocarcinome de la prostate
|
|
EP1610818A4
(en)
|
2004-03-03 |
2007-09-19 |
Millennium Pharm Inc |
MODIFIED ANTIBODIES AGAINST A PROSTATE-SPECIFIC MEMBRANE-ANTIGEN AND USE THEREOF
|
|
ES2311895T3
(es)
*
|
2004-03-15 |
2009-02-16 |
F. Hoffmann-La Roche Ag |
El uso de los peptidos tipo bnp y de los peptidos tipo anf para evaluar el riesgo de padecer una complicacion cardio-vascular como frecuencia de sobrecarga del volumen.
|
|
EP1756166A4
(en)
|
2004-04-19 |
2008-08-27 |
Proscan Rx Pharma |
DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
|
|
US20060105975A1
(en)
*
|
2004-04-19 |
2006-05-18 |
Shannon Pendergrast |
Aptamer-mediated intracellular delivery of therapeutic oligonucleotides
|
|
JP4806680B2
(ja)
*
|
2004-05-19 |
2011-11-02 |
メダレックス インコーポレイテッド |
自己犠牲リンカー及び薬剤複合体
|
|
RU2402548C2
(ru)
*
|
2004-05-19 |
2010-10-27 |
Медарекс, Инк. |
Химические линкеры и их конъюгаты
|
|
US20080008719A1
(en)
|
2004-07-10 |
2008-01-10 |
Bowdish Katherine S |
Methods and compositions for the treatment of prostate cancer
|
|
JP5149620B2
(ja)
|
2004-07-23 |
2013-02-20 |
エンドサイト，インコーポレイテッド |
２価リンカーおよびその結合体
|
|
PL1776384T3
(pl)
|
2004-08-04 |
2013-10-31 |
Mentrik Biotech Llc |
WARIANTY REGIONÓW Fc
|
|
MX2007002410A
(es)
|
2004-08-30 |
2007-05-07 |
Neuromed Pharmaceuticals Ltd |
Derivados de urea como bloqueadores de canal de calcio.
|
|
US7713944B2
(en)
*
|
2004-10-13 |
2010-05-11 |
Isis Pharmaceuticals, Inc. |
Oligomers comprising activated disulfides which bind to plasma proteins and their use for delivery to cells
|
|
WO2006049891A1
(en)
|
2004-10-27 |
2006-05-11 |
Janssen Pharmaceutica N.V. |
Trisubstituted thiophenes as progesterone receptor modulators
|
|
EP1827505A4
(en)
|
2004-11-09 |
2017-07-12 |
Biosensors International Group, Ltd. |
Radioimaging
|
|
US8423125B2
(en)
|
2004-11-09 |
2013-04-16 |
Spectrum Dynamics Llc |
Radioimaging
|
|
US20060140871A1
(en)
|
2004-11-30 |
2006-06-29 |
Sillerud Laurel O |
Magnetic resonance imaging of prostate cancer
|
|
US7872235B2
(en)
|
2005-01-13 |
2011-01-18 |
Spectrum Dynamics Llc |
Multi-dimensional image reconstruction and analysis for expert-system diagnosis
|
|
US7741510B2
(en)
|
2005-01-13 |
2010-06-22 |
E. I. Du Pont De Nemours And Company |
Rheology control agents
|
|
US20060155021A1
(en)
|
2005-01-13 |
2006-07-13 |
Lenges Christian P |
Coating compositions containing rheology control agents
|
|
US20090258002A1
(en)
|
2005-02-01 |
2009-10-15 |
Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services |
Biomarkers for Tissue Status
|
|
WO2006093991A1
(en)
|
2005-03-02 |
2006-09-08 |
The Cleveland Clinic Foundation |
Compounds which bind psma and uses thereof
|
|
WO2006096754A2
(en)
|
2005-03-07 |
2006-09-14 |
Archemix Corp. |
Stabilized aptamers to psma and their use as prostate cancer therapeutics
|
|
US8088908B2
(en)
|
2005-05-10 |
2012-01-03 |
City Of Hope |
Humanized anti-prostate stem cell antigen monoclonal antibody
|
|
KR101068612B1
(ko)
|
2005-05-24 |
2011-09-30 |
휴마시스 주식회사 |
유사구조 단백질 비율 측정을 이용한 진단장치
|
|
EP1891093B1
(en)
|
2005-06-14 |
2011-03-23 |
Protox Therapeutics Incorporated |
Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins
|
|
NZ565075A
(en)
*
|
2005-06-20 |
2011-05-27 |
Psma Dev Company Llc |
PSMA antibody-drug conjugates
|
|
US7403088B2
(en)
|
2005-06-29 |
2008-07-22 |
Eaton Corporation |
Handle apparatus and electrical switching apparartus employing the same
|
|
US20070009434A1
(en)
|
2005-07-05 |
2007-01-11 |
Low Philip S |
Imaging and therapeutic method using monocytes
|
|
US20070010014A1
(en)
*
|
2005-07-06 |
2007-01-11 |
General Electric Company |
Compositions and methods for enhanced delivery to target sites
|
|
EP1909853B1
(en)
|
2005-07-19 |
2015-03-18 |
Biosensors International Group, Ltd. |
Imaging protocols
|
|
EP2382995A3
(en)
|
2005-08-19 |
2013-09-25 |
Endocyte, Inc. |
Ligand conjugates of Vinca alkaloids, analogs and derivatives
|
|
AU2006279304A1
(en)
|
2005-08-19 |
2007-02-22 |
Endocyte, Inc. |
Multi-drug ligand conjugates
|
|
US20100144641A1
(en)
|
2005-09-12 |
2010-06-10 |
Popel Aleksander S |
Compositions Having Antiangiogenic Activity and Uses Thereof
|
|
EP1940841B9
(fr)
|
2005-10-07 |
2017-04-19 |
Guerbet |
Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
|
|
WO2008048298A2
(en)
*
|
2005-11-21 |
2008-04-24 |
Medivas, Llc |
Polymer particles for delivery of macromolecules and methods of use
|
|
DK2963011T3
(en)
*
|
2005-11-23 |
2018-08-06 |
Ventana Med Syst Inc |
MOLECULAR CONJUGATE
|
|
WO2007081751A2
(en)
|
2006-01-05 |
2007-07-19 |
The Johns Hopkins University |
Compositions and methods for the treatment of cancer
|
|
US7635682B2
(en)
|
2006-01-06 |
2009-12-22 |
Genspera, Inc. |
Tumor activated prodrugs
|
|
JP2009532338A
(ja)
*
|
2006-03-14 |
2009-09-10 |
キャンサー ターゲテッド テクノロジー エルエルシー |
Ｐｓｍａのペプチド模倣体阻害剤、それらを含む化合物、およびそれらの使用方法
|
|
WO2007109321A2
(en)
|
2006-03-20 |
2007-09-27 |
The Regents Of The University Of California |
Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
|
|
US20070225213A1
(en)
|
2006-03-23 |
2007-09-27 |
Kosak Matthew K |
Nucleic acid carriers for delivery of therapeutic agents
|
|
US20140314864A1
(en)
|
2006-03-31 |
2014-10-23 |
Massachusetts Institute Of Technology |
System for Targeted Delivery of Therapeutic Agents
|
|
ES2776100T3
(es)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
|
US7842280B2
(en)
*
|
2006-09-06 |
2010-11-30 |
Case Western Reserve University |
Flexibly labeling peptides
|
|
JP2010509570A
(ja)
*
|
2006-11-03 |
2010-03-25 |
パーデュー・リサーチ・ファウンデーション |
エクスビボフローサイトメトリーの方法および装置
|
|
ES2847275T3
(es)
|
2006-11-08 |
2021-08-02 |
Molecular Insight Pharm Inc |
Heterodímeros de ácido glutámico
|
|
US8956602B2
(en)
*
|
2006-12-05 |
2015-02-17 |
Landec, Inc. |
Delivery of drugs
|
|
WO2008085828A2
(en)
|
2007-01-03 |
2008-07-17 |
The Johns Hopkins University |
Peptide modulators of angiogenesis and use thereof
|
|
AU2007343600B2
(en)
|
2007-01-11 |
2012-06-28 |
Immunomedics, Inc. |
Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
|
|
US20080214436A1
(en)
*
|
2007-01-26 |
2008-09-04 |
City Of Hope |
Methods and compositions for the treatment of cancer or other diseases
|
|
US8586595B2
(en)
|
2007-02-07 |
2013-11-19 |
Purdue Research Foundation |
Positron emission tomography imaging method
|
|
WO2008101231A2
(en)
|
2007-02-16 |
2008-08-21 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
CN104127878A
(zh)
*
|
2007-03-14 |
2014-11-05 |
恩多塞特公司 |
结合配体连接的微管溶素递药缀合物
|
|
EP2136788B1
(en)
|
2007-03-30 |
2011-10-26 |
Bind Biosciences, Inc. |
Cancer cell targeting using nanoparticles
|
|
WO2008124197A1
(en)
|
2007-04-10 |
2008-10-16 |
The Johns Hopkins University |
Imaging and therapy of virus-associated tumors
|
|
BRPI0812970A2
(pt)
|
2007-06-25 |
2019-09-24 |
Endocyte Inc |
conjugados contendo espaçadores hidrofílicos
|
|
CA2926573C
(en)
|
2007-06-26 |
2018-08-28 |
The Johns Hopkins University |
Labeled inhibitors of prostate specific membrane antigen (psma), biological evaluation, and use as imaging agents
|
|
GB0723246D0
(en)
|
2007-07-03 |
2008-01-09 |
Barton Michelle |
p53 modulator
|
|
EP2170946A2
(en)
|
2007-07-13 |
2010-04-07 |
The Johns Hopkins University |
B7-dc variants
|
|
RU2010107199A
(ru)
|
2007-07-31 |
2011-09-10 |
Дзе Джонс Хопкинс Юниверсити (Us) |
Конъюгат полипептид-нуклеиновая кислота для иммунопрофилактики или иммунотерапии для неопластических или инфекционных нарушений
|
|
EP4464384A3
(en)
|
2007-08-17 |
2025-01-08 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
WO2009035942A1
(en)
|
2007-09-13 |
2009-03-19 |
Chemimage Corporation |
Distinguishing between renal oncocytoma and chromophobe renal cell carcinoma using raman molecular imaging
|
|
US9187521B2
(en)
*
|
2007-10-25 |
2015-11-17 |
Endocyte, Inc. |
Tubulysins and processes for preparing
|
|
US8450290B2
(en)
|
2007-11-26 |
2013-05-28 |
Enzon Pharmaceuticals, Inc. |
Methods for treating androgen receptor dependent disorders including cancers
|
|
WO2009070302A1
(en)
|
2007-11-30 |
2009-06-04 |
The Johns Hopkins University |
Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer
|
|
EP2231194B1
(en)
|
2007-12-04 |
2017-02-22 |
Alnylam Pharmaceuticals Inc. |
Folate-irna conjugates
|
|
WO2009076434A1
(en)
|
2007-12-12 |
2009-06-18 |
Molecular Insight Pharmaceuticals, Inc. |
Inhibitors of integrin vla-4
|
|
CA2711678A1
(en)
|
2008-01-09 |
2009-07-16 |
Molecular Insight Pharmaceuticals, Inc. |
Inhibitors of carbonic anhydrase ix
|
|
ITTO20080313A1
(it)
|
2008-04-22 |
2009-10-23 |
Marco Colombatti |
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi
|
|
US8258111B2
(en)
|
2008-05-08 |
2012-09-04 |
The Johns Hopkins University |
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
|
|
SI2291659T1
(sl)
|
2008-05-13 |
2016-02-29 |
Yale University |
Himerične majhne molekule za pridobivanje protiteles za rakave celice
|
|
US8852630B2
(en)
|
2008-05-13 |
2014-10-07 |
Yale University |
Chimeric small molecules for the recruitment of antibodies to cancer cells
|
|
JP2012501965A
(ja)
*
|
2008-06-16 |
2012-01-26 |
バインド バイオサイエンシズ インコーポレイテッド |
薬剤を装填したポリマーナノ粒子及びその製造方法と使用方法
|
|
RU2494096C2
(ru)
|
2008-08-01 |
2013-09-27 |
Дзе Джонс Хопкинс Юниверсити |
Агенты, связывающиеся с psma, и их применение
|
|
CA2734322A1
(en)
|
2008-08-15 |
2010-02-18 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
EP2326350B1
(en)
|
2008-09-08 |
2013-09-04 |
Psma Development Company, L.L.C. |
Compounds for killing psma-expressing, taxane-resistant cancer cells
|
|
EP2166021A1
(en)
|
2008-09-16 |
2010-03-24 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies for treatment of cancer
|
|
AU2009293140A1
(en)
|
2008-09-17 |
2010-03-25 |
Endocyte, Inc. |
Folate receptor binding conjugates of antifolates
|
|
WO2010045598A2
(en)
|
2008-10-17 |
2010-04-22 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
WO2010065899A2
(en)
|
2008-12-05 |
2010-06-10 |
Molecular Insight Pharmaceuticals, Inc. |
Technetium-and rhenium-bis(heteroaryl)complexes and methods of use thereof
|
|
WO2010065906A2
(en)
|
2008-12-05 |
2010-06-10 |
Molecular Insight Pharmaceuticals, Inc. |
Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer
|
|
TW201034691A
(en)
|
2008-12-05 |
2010-10-01 |
Molecular Insight Pharm Inc |
Technetium-and rhenium-bis(heteroaryl) complexes and methods of use thereof
|
|
EP2398504B1
(en)
|
2009-02-17 |
2018-11-28 |
Cornell Research Foundation, Inc. |
Methods and kits for diagnosis of cancer and prediction of therapeutic value
|
|
US8772226B2
(en)
|
2009-03-17 |
2014-07-08 |
The Johns Hopkins University |
Methods and compositions for the detection of cancer
|
|
EP3222617B1
(en)
|
2009-03-19 |
2022-07-06 |
The Johns Hopkins University |
Psma-targeting compounds and uses thereof
|
|
AU2010260195B2
(en)
|
2009-06-15 |
2014-11-20 |
Molecular Insight Pharmaceuticals, Inc. |
Process for production of heterodimers of glutamic acid
|
|
EP2460013A4
(en)
|
2009-07-31 |
2013-04-03 |
Endocyte Inc |
ON FOLLOWING DIAGNOSIS AND TREATMENT
|
|
US8394922B2
(en)
|
2009-08-03 |
2013-03-12 |
Medarex, Inc. |
Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
|
|
US8313128B2
(en)
|
2009-08-20 |
2012-11-20 |
Rhoost, Llc. |
Safety locking mechanism for doors
|
|
WO2011031517A1
(en)
|
2009-08-27 |
2011-03-17 |
Nuclea Biotechnologies, LLC |
Method and assay for determining fas expression
|
|
CA2782333C
(en)
|
2009-12-02 |
2019-06-04 |
Imaginab, Inc. |
J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
|
|
US8357401B2
(en)
|
2009-12-11 |
2013-01-22 |
Bind Biosciences, Inc. |
Stable formulations for lyophilizing therapeutic particles
|
|
MX338831B
(es)
|
2010-02-04 |
2016-05-03 |
Radius Health Inc |
Moduladores selectivos de receptores de androgenos.
|
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
CA2790577A1
(en)
|
2010-02-25 |
2011-09-01 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
CN101863924B
(zh)
|
2010-05-17 |
2012-06-27 |
北京师范大学 |
99mTc标记肼基烟酰胺基-二氧辛酰-叶酸配合物及制备方法
|
|
US9687572B2
(en)
|
2010-12-06 |
2017-06-27 |
Molecular Insight Pharmaceuticals, Inc. |
PSMA-targeted dendrimers
|
|
WO2012166923A2
(en)
|
2011-05-31 |
2012-12-06 |
Bind Biosciences |
Drug loaded polymeric nanoparticles and methods of making and using same
|
|
WO2013022797A1
(en)
|
2011-08-05 |
2013-02-14 |
Molecular Insight Pharmaceuticals |
Radiolabeled prostate specific membrane antigen inhibitors
|
|
WO2013028664A1
(en)
|
2011-08-22 |
2013-02-28 |
Siemens Medical Solutions Usa, Inc. |
Psma imaging agents
|
|
EP2822386B1
(en)
|
2012-02-29 |
2021-05-05 |
Purdue Research Foundation |
Folate receptor alpha binding ligands
|
|
EP2908818A4
(en)
|
2012-10-16 |
2016-07-13 |
Endocyte Inc |
CONJUGATES OF DRUG DELIVERY CONTAINING ARTIFICIAL AMINO ACIDS AND METHODS OF USE
|
|
US20140107316A1
(en)
*
|
2012-10-16 |
2014-04-17 |
Endocyte, Inc. |
Drug delivery conjugates containing unnatural amino acids and methods for using
|
|
BR112015011118B1
(pt)
|
2012-11-15 |
2022-12-13 |
Endocyte, Inc |
Conjugado; composição farmacêutica; e uso de um conjugado
|
|
US20140154702A1
(en)
|
2012-11-30 |
2014-06-05 |
Endocyte, Inc. |
Methods For Treating Cancer Using Combination Therapies
|
|
CN105246894A
(zh)
|
2012-12-21 |
2016-01-13 |
斯皮罗根有限公司 |
用于治疗增殖性和自身免疫疾病的非对称吡咯并苯并二氮杂卓二聚物
|
|
US20140187501A1
(en)
|
2012-12-28 |
2014-07-03 |
Blend Therapeutics, Inc. |
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
|
|
EP2958596B1
(en)
|
2013-02-15 |
2019-12-04 |
Case Western Reserve University |
Psma ligands and uses thereof
|
|
US20140249315A1
(en)
|
2013-03-01 |
2014-09-04 |
Endocyte, Inc. |
Processes for preparing tubulysins
|
|
US20170232119A1
(en)
*
|
2013-03-15 |
2017-08-17 |
Purdue Research Foundation |
Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
|
|
US10406246B2
(en)
|
2013-10-17 |
2019-09-10 |
Deutsches Kresbsforschungszentrum |
Double-labeled probe for molecular imaging and use thereof
|
|
LT4095130T
(lt)
|
2013-10-18 |
2024-04-25 |
Novartis Ag |
Žymėti prostatos specifinio membranos antigeno (psma) inhibitoriai, jų naudojimas kaip vizualizavimo medžiagų ir farmacinių medžiagų prostatos vėžiui gydyti
|
|
US20150110814A1
(en)
|
2013-10-18 |
2015-04-23 |
Psma Development Company, Llc |
Combination therapies with psma ligand conjugates
|
|
BR112016010927A2
(pt)
|
2013-11-14 |
2017-08-08 |
Endocyte Inc |
Conjugado de fórmula
|
|
AU2015256002B2
(en)
|
2014-05-06 |
2020-01-02 |
Northwestern University |
Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy
|
|
EP3183236B1
(en)
|
2014-08-24 |
2022-04-20 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften |
Method for the production of 18f-labeled active esters and their application exemplified by the preparation of a psma-specific pet-tracer
|
|
AU2015315465B2
(en)
|
2014-09-08 |
2019-08-29 |
Molecular Insight Pharmaceuticals, Inc. |
Organ protection in PSMA-targeted radionuclide therapy of prostate cancer
|
|
WO2016183131A1
(en)
*
|
2015-05-11 |
2016-11-17 |
Purdue Research Foundation |
Ligand ionophore conjugates
|
|
US9808538B2
(en)
*
|
2015-09-09 |
2017-11-07 |
On Target Laboratories, LLC |
PSMA-targeted NIR dyes and their uses
|
|
US10842887B2
(en)
*
|
2015-09-09 |
2020-11-24 |
On Target Laboratories, LLC |
PSMA-targeted NIR dyes and their uses
|
|
FR3043970B1
(fr)
|
2015-11-25 |
2019-06-21 |
Medtech Sa |
Systeme mecanique de stabilisation au sol pour vehicules a roulettes
|
|
JP6806471B2
(ja)
|
2016-06-16 |
2021-01-06 |
キヤノン株式会社 |
焦点検出装置及び方法、及び撮像装置
|
|
EP3510399B1
(en)
*
|
2016-09-09 |
2023-03-01 |
On Target Laboratories, LLC |
Psma-targeted nir dyes and their uses
|